Page 83 - Read Online

Page 16 of 19 Shi et al. J Cancer Metastasis Treat 2018;4:47 I http://dx.doi.org/10.20517/2394-4722.2018.32

3CA mutations on response to EGFR tyrosine kinase inhibition in EGFR-mutant lung cancers and on prognosis in oncogene-driven lung
adenocarcinomas. J Thorac Oncol 2015;10:1713-9.
32. Kim C, Gao R, Sei E, Brandt R, Hartman J, Hatschek T, Crosetto N, Foukakis T, Navin NE. Chemoresistance evolution in triple-negative
breast cancer delineated by single-cell sequencing. Cell 2018;173:879-93.e13.
33. Turner NC, Reis-Filho JS. Genetic heterogeneity and cancer drug resistance. Lancet Oncol 2012;13:e178-85.
34. Danielsen HE, Pradhan M, Novelli M. Revisiting tumour aneuploidy—the place of ploidy assessment in the molecular era. Nat Rev Clin
Oncol 2016;13:291.
35. Cyll K, Ersvær E, Vlatkovic L, Pradhan M, Kildal W, Avranden Kjær M, Kleppe A, Hveem TS, Carlsen B, Gill S, Löffeler S, Haug ES,
Wæhre H, Sooriakumaran P, Danielsen HE. Tumour heterogeneity poses a significant challenge to cancer biomarker research. Br J Cancer
2017;117:367.
36. Wei SH, Chen C-M, Strathdee G, Harnsomburana J, Shyu C-R, Rahmatpanah F, Shi H, Ng S-W, Yan PS, Nephew KP, Brown R, Huang
TH-M. Methylation microarray analysis of late-stage ovarian carcinomas distinguishes progression-free survival in patients and identifies
candidate epigenetic markers. Clin Cancer Res 2002;8:2246-52.
37. Wei SH, Balch C, Paik HH, Kim Y-S, Baldwin RL, Liyanarachchi S, Li L, Wang Z, Wan JC, Davuluri RV, Karlan BY, Gifford G, Brown R,
Kim S, Huang TH-M, Nephew KP. Prognostic DNA methylation biomarkers in ovarian cancer. Clin Cancer Res 2006;12:2788-94.
38. Rajaram S, Heinrich LE, Gordan JD, Avva J, Bonness KM, Witkiewicz AK, Malter JS, Atreya CE, Warren RS, Wu LF, Altschuler SJ. Sam-
pling strategies to capture single-cell heterogeneity. Nat Methods 2017;14:967.
39. Foley JW, Zhu C, Jolivet P, Zhu SX, Lu P, Meaney MJ, West RB. Gene-expression profiling of single cells from archival tissue with laser-
capture microdissection and Smart-3SEQ. bioRxiv 2018; doi: 10.1101/207340.
40. Hayashida Y, Partida GJ, Ishida AT. Dissociation of retinal ganglion cells without enzymes. J Neurosci Methods 2004;137:25-35.
41. Gomez GG, Kruse CA. Isolation and culture of human brain tumor cells. Cancer Cell Culture. Methods Mol Med: Springer; 2004. p. 101-9.
42. Louis SA, Mak CK, Reynolds BA. Methods to culture, differentiate, and characterize neural stem cells from the adult and embryonic mouse
central nervous system. Methods Mol Biol: Springer; 2013. p. 479-506.
43. Patel AP, Tirosh I, Trombetta JJ, Shalek AK, Gillespie SM, Wakimoto H, Cahill DP, Nahed BV, Curry WT, Martuza RL, Louis DN, Rozen-
blatt-Rosen O, Suvà ML, Regev A, Bernstein BE. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Sci-
ence 2014;344:1396-401.
44. Yan Y, Xu Y, Gao YY, Zong ZH, Zhang Q, Li C, Wang HQ. Implication of 14-3-3ε and 14-3-3θ/τ in proteasome inhibition-induced apopto-
sis of glioma cells. Cancer Sci 2013;104:55-61.
45. Panchision DM, Chen HL, Pistollato F, Papini D, Ni HT, Hawley TS. Optimized flow cytometric analysis of central nervous system tissue
reveals novel functional relationships among cells expressing CD133, CD15, and CD24. Stem Cells 2007;25:1560-70.
46. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, Fiocco R, Foroni C, Dimeco F, Vescovi A. Isolation and characterization of
tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 2004;64:7011-21.
47. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB. Identification of human brain
tumour initiating cells. Nature 2004;432:396.
48. Wolters GH, Vos-Scheperkeuter GH, Lin H-C, van Schilfgaarde R. Different roles of class I and class II Clostridium histolyticum collage-
nase in rat pancreatic islet isolation. Diabetes 1995;44:227-33.
49. Maric D, Barker JL. Neural stem cells redefined. Mol Neurobiol 2004;30:49-76.
50. Espina V, Wulfkuhle JD, Calvert VS, VanMeter A, Zhou W, Coukos G, Geho DH, Petricoin III EF, Liotta LA. Laser-capture microdissec-
tion. Nat Protoc 2006;1:586.
51. Obiakor H, Sehgal D, Dasso JF, Bonner RF, Malekafzali A, Mage RG. A comparison of hydraulic and laser capture microdissection meth-
ods for collection of single B cells, PCR, and sequencing of antibody VDJ. Anal Biochem 2002;306:55-62.
52. Suarez-Quian C, Goldstein S, Pohida T, Smith P, Peterson J, Wellner E, Ghany M, Bonner R. Laser capture microdissection of single cells
from complex tissues. BioTechniques 1999;26:328-35.
53. Keays KM, Owens GP, Ritchie AM, Gilden DH, Burgoon MP. Laser capture microdissection and single-cell RT-PCR without RNA purifi-
cation. J Immunol Methods 2005;302:90-8.
54. Dasgupta A, Lim AR, Ghajar CM. Circulating and disseminated tumor cells: harbingers or initiators of metastasis? Mol Oncol 2017;11:40-
61.
55. Heitzer E, Auer M, Gasch C, Pichler M, Ulz P, Hoffmann EM, Lax S, Waldispuehl-Geigl J, Mauermann O, Lackner C, Höfler G, Eisner F,
Sill H, Samonigg H, Pantel K, Riethdorf S, Bauernhofer T, Geigl JB, Speicher MR. Complex tumor genomes inferred from single circulat-
ing tumor cells by array-CGH and next-generation sequencing. Cancer Res 2013;73:2965-75.
56. Ni X, Zhuo M, Su Z, Duan J, Gao Y, Wang Z, Zong C, Bai H, Chapman AR, Zhao J, Xu L, An T, Ma Q, Wang Y, Wu M, Sun Y, Wang S, Li Z,
Yang X, Yong J, Su X-D, Lu Y, Bai F, Xie XS, Wang J. Reproducible copy number variation patterns among single circulating tumor cells
of lung cancer patients. Proc Natl Acad Sci U S A 2013;110:21083-8.
57. Rantalainen M. Application of single-cell sequencing in human cancer. Brief Funct Genomics 2018;17:273-82.
58. Lohr JG, Adalsteinsson VA, Cibulskis K, Choudhury AD, Rosenberg M, Cruz-Gordillo P, Francis JM, Zhang C-Z, Shalek AK, Satija R,
Trombetta JJ, Lu D, Tallapragada N, Tahirova N, Kim S, Blumenstiel B, Sougnez C, Lowe A, Wong B, Auclair D, Van Allen EM, Naka-
bayashi M, Lis RT, Lee G-SM, Li T, Chabot MS, Ly A, Taplin M-E, Clancy TE, Loda M, Regev A, Meyerson M, Hahn WC, Kantoff PW,
Golub TR, Getz G, Boehm JS, Love JC. Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate
cancer. Nat Biotechnol 2014;32:479.
59. Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 2006;12:895.
60. Gabriel MT, Calleja LR, Chalopin A, Ory B, Heymann D. Circulating tumor cells: a review of non-EpCAM-based approaches for cell en-
richment and isolation. Clin Chem 2016;62:571-81.
61. Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, Ulkus L, Smith MR, Kwak EL, Digumarthy S, Muzikansky A, Ryan P, Balis